Celltrion Begins Supplying COVID-19 Antibody Treatment

SEOUL, Feb. 17 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. began supplying its COVID-19 antibody treatment to medical institutions in the country Wednesday. CT-P59 won the drug safety agency’s conditional approval earlier this month, becoming the first locally made treatment for COVID-19. CT-P59 will be administered to COVID-19 patients at higher risk, referring [...]